Publication: Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma
Submitted Date
Received Date
Accepted Date
Issued Date
2008-12-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
08864470
08864470
08864470
eISSN
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-58149234928
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Archives of Otolaryngology - Head and Neck Surgery. Vol.134, No.12 (2008), 1305-1311
Citation
Vipa Boonkitticharoen, Boonchu Kulapaditharom, Juvady Leopairut, Puangtong Kraiphibul, Noppadol Larbcharoensub, Wichit Cheewaruangroj, Chalermchai Chintrakarn, Lucksana Pochanukul (2008). Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma. Retrieved from: https://hdl.handle.net/20.500.14594/19438.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma
Alternative Title(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Objective: To explore the effect of Ki-67 and vascular endothelial growth factor A (VEGF-A) expression on the risks of advanced T category (T3,4) and positive lymph node involvement (N+) in oral and pharyngeal squamous cell carcinoma (SCC) compared with laryngeal SCC. Design: Immunohistochemical analysis of prospectively recruited patients. Setting: University-affiliated hospital. Patients: A total of 147 previously untreated patients with different stages of SCC in the oral cavity, pharynx, and larynx. Main Outcome Measures: Relative risks of T3,4 tumor and N+, a risk ratio comparing risks under high vs low marker expression. Results: A significant association of Ki-67 and VEGF-A expression with tumor T category was observed for oral and pharyngeal SCC and for laryngeal SCC (P≤.006). Regarding nodal status, Ki-67 expression was a significant risk factor for N+ in all tumors (P≤.009), whereas VEGF-A expression was related to N+ in oral and pharyngeal SCC only (P<.03). Analytically, Ki-67 expression alone in oral and pharyngeal SCC was associated with a relative risk of N+ of 3.83(95% confidence interval, 1.22-11.99; P=.009),and additional expression of VEGF-A raised the value to 6.12 (2.09-17.93;P<.001). Moreover, the combined expression of both markers was 3.25 times more effective in predicting N+ for T1,2 tumor compared with T3,4 tumor. Conclusions: Proliferative status was a common risk factor for N+ in all of the tumors in this series. Exploitation of VEGF-A in lymph node metastasis in addition to proliferation by oral and pharyngeal SCC but not by laryngeal SCC explains the clinical aggressiveness of oral and pharyngeal SCC, especially the early lymphatic invasion. In the management of cervical lymph nodes, combined expression of Ki-67 and VEGF-A may help identify patients at risk for occult metastases. This study suggests anti-VEGF-A therapy, an additional intervention to the classic antiproliferative regimen, for preventing lymphatic progression of oral and pharyngeal SCC. ©2008 American Medical Association. All rights reserved.